654 related articles for article (PubMed ID: 34199023)
1. Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature.
Martinotti G; Chiappini S; Pettorruso M; Mosca A; Miuli A; Di Carlo F; D'Andrea G; Collevecchio R; Di Muzio I; Sensi SL; Di Giannantonio M
Brain Sci; 2021 Jun; 11(7):. PubMed ID: 34199023
[TBL] [Abstract][Full Text] [Related]
2. Clinical Effectiveness of N-Methyl-D-Aspartate (NMDA) Receptor Antagonists in Adult Obsessive-Compulsive Disorder (OCD) Treatment: A Systematic Review.
Ferguson AA; Khan AI; Abuzainah B; Chaudhuri D; Khan KI; Al Shouli R; Allakky A; Hamdan JA
Cureus; 2023 Apr; 15(4):e37833. PubMed ID: 37213965
[TBL] [Abstract][Full Text] [Related]
3. Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments.
Fontenelle LF; Oostermeijer S; Harrison BJ; Pantelis C; Yücel M
Drugs; 2011 May; 71(7):827-40. PubMed ID: 21568361
[TBL] [Abstract][Full Text] [Related]
4. [Current and lifetime prevalence of obsessive compulsive disorders in eating disorders].
Speranza M; Corcos M; Godart N; Jeammet P; Flament M
Encephale; 2001; 27(6):541-50. PubMed ID: 11865561
[TBL] [Abstract][Full Text] [Related]
5. The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report.
Matteo M; Cristian P; Laura M; Federico M; Chiara R; Lorenzo G; Michaela K; Sibilla M; Roberto N; Fabrizia C; Antonios D; Alice C; Enrico C; Beatrice B; Francesca B; Nicoletta V; Alberto P; Silvia I; Massimo C
Ann Gen Psychiatry; 2021 Sep; 20(1):43. PubMed ID: 34530843
[TBL] [Abstract][Full Text] [Related]
6. Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review.
Alves-Pereira R; Fontes M; Cordeiro V; Bandeira ID; Faria-Guimarães D; Silva SS; Mello RP; Leal GC; Sampaio AS; Quarantini LC
Clin Neuropharmacol; 2024 Jan-Feb 01; 47(1):17-21. PubMed ID: 38194244
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.
Rodriguez CI; Kegeles LS; Levinson A; Feng T; Marcus SM; Vermes D; Flood P; Simpson HB
Neuropsychopharmacology; 2013 Nov; 38(12):2475-83. PubMed ID: 23783065
[TBL] [Abstract][Full Text] [Related]
8. [Eating disorders (ED) and obsessive-compulsive disorders (OCD): common factors].
Bertrand A; Bélanger C; O'Connor K
Sante Ment Que; 2011; 36(1):149-79. PubMed ID: 21983909
[TBL] [Abstract][Full Text] [Related]
9. Trauma-related obsessive-compulsive disorder: a review.
Dykshoorn KL
Health Psychol Behav Med; 2014 Jan; 2(1):517-528. PubMed ID: 25750799
[TBL] [Abstract][Full Text] [Related]
10. Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review.
Bandeira ID; Lins-Silva DH; Cavenaghi VB; Dorea-Bandeira I; Faria-Guimarães D; Barouh JL; Jesus-Nunes AP; Beanes G; Souza LS; Leal GC; Sanacora G; Miguel EC; Sampaio AS; Quarantini LC
Harv Rev Psychiatry; 2022 Mar-Apr 01; 30(2):135-145. PubMed ID: 35267254
[TBL] [Abstract][Full Text] [Related]
11. Obsessive-compulsive spectrum disorders.
Allen A; King A; Hollander E
Dialogues Clin Neurosci; 2003 Sep; 5(3):259-71. PubMed ID: 22033547
[TBL] [Abstract][Full Text] [Related]
12. Comorbid obsessive-compulsive disorder in individuals with eating disorders: An epidemiological meta-analysis.
Drakes DH; Fawcett EJ; Rose JP; Carter-Major JC; Fawcett JM
J Psychiatr Res; 2021 Sep; 141():176-191. PubMed ID: 34216946
[TBL] [Abstract][Full Text] [Related]
13. [Combination of ketamine and esketamine with Exposure and Response Prevention (ERP) therapy for Obsessive-Compulsive Disorder].
Bottemanne H; Arnould A; Najar A; Delaigue F; Serresse L; Joly L; Mouchabac S
Encephale; 2023 Jun; 49(3):304-311. PubMed ID: 37095049
[TBL] [Abstract][Full Text] [Related]
14. Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions.
Ragnhildstveit A; Slayton M; Jackson LK; Brendle M; Ahuja S; Holle W; Moore C; Sollars K; Seli P; Robison R
Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326338
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric Comorbidity Among Eating Disorders and Obsessive-Compulsive Disorder and Underlying Shared Mechanisms and Features: An Updated Review.
Williams BM; Brown ML; Sandoval-Araujo L; Russell S; Levinson CA
J Cogn Psychother; 2022 Jul; 36(3):226-246. PubMed ID: 35882534
[TBL] [Abstract][Full Text] [Related]
16. Perfectionism and Difficulty Controlling Thoughts Bridge Eating Disorder and Obsessive-Compulsive Disorder Symptoms: A Network Analysis.
Vanzhula IA; Kinkel-Ram SS; Levinson CA
J Affect Disord; 2021 Mar; 283():302-309. PubMed ID: 33578342
[TBL] [Abstract][Full Text] [Related]
17. Orthorexia Nervosa, Eating Disorders, and Obsessive-Compulsive Disorder: A Selective Review of the Last Seven Years.
Pontillo M; Zanna V; Demaria F; Averna R; Di Vincenzo C; De Biase M; Di Luzio M; Foti B; Tata MC; Vicari S
J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294454
[TBL] [Abstract][Full Text] [Related]
18. The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS).
Kwan ATH; Rosenblat JD; Mansur RB; Teopiz KM; McIntyre RS
J Affect Disord; 2024 Sep; 360():421-426. PubMed ID: 38795777
[TBL] [Abstract][Full Text] [Related]
19. Rates of comorbid obsessive-compulsive disorder in eating disorders: A meta-analysis of the literature.
Mandelli L; Draghetti S; Albert U; De Ronchi D; Atti AR
J Affect Disord; 2020 Dec; 277():927-939. PubMed ID: 33065835
[TBL] [Abstract][Full Text] [Related]
20. Common neurofunctional dysregulations characterize obsessive-compulsive, substance use, and gaming disorders-An activation likelihood meta-analysis of functional imaging studies.
Klugah-Brown B; Zhou X; Pradhan BK; Zweerings J; Mathiak K; Biswal B; Becker B
Addict Biol; 2021 Jul; 26(4):e12997. PubMed ID: 33432718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
